Published Date: 31-May-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Digital Diabetes Management Market size is expected to reach $29.5 billion by 2028, rising at a market growth of 12.0% CAGR during the forecast period.
The Wearables segment acquired maximum revenue share the Global Digital Diabetes Management Market by Type in 2021, thereby, achieving a market value of $17.7 billion by 2028. The wearable segment acquired the largest revenue share in the digital diabetes management market in 2021. This is due to these devices providing crucial data to the user. CGM systems, smart insulin pumps, and smart insulin patches are examples of wearable devices.
The Data Management Software & Platforms segment is showcasing highest CAGR of 12.4% during (2022 - 2028). The data management software and platforms segment procured a significant revenue share in the digital diabetes management market in 2021. Data management software (DMS) collects data and turns it into a single storage container or combines it into a consistent resource, such as a database.
The Self/Home Healthcare segment generating highest revenue share the Global Digital Diabetes Management Market by End User in 2021, thereby, achieving a market value of $18.5 billion by 2028. The self/home healthcare segment acquired the largest revenue share in the digital diabetes management market in 2021. This is due to the chronic nature of the disease which requires continuous care. Self/home care digital diabetes management systems and platforms have improved in accuracy, low invasiveness, and ease of use as a result of technological improvements.
The North America market dominated the Global Digital Diabetes Management Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $10.3 billion by 2028. The Europe market is estimated to grow a CAGR of 11.7% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 12.6% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Abbott Laboratories, Terumo Corporation, F. Hoffmann-La Roche Ltd., DexCom, Inc., Novo Nordisk A/S, ACON Laboratories, Inc., Bayer AG, B. Braun Melsungen AG, and Azumio, Inc.
By Product & Service
By End User
Unique Offerings from KBV Research